$595 Million is the total value of SECTOR GAMMA AS's 36 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 42.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABT | Sell | ABBOTT LABS | $61,627,000 | -9.2% | 1,079,842 | -15.1% | 10.36% | +0.2% |
| BAX | Sell | BAXTER INTL INC | $44,888,000 | -23.4% | 694,438 | -25.7% | 7.54% | -15.5% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $42,165,000 | -1.6% | 1,700,880 | +15.8% | 7.09% | +8.5% |
| PKI | Sell | PERKINELMER INC | $32,232,000 | -13.7% | 440,808 | -18.6% | 5.42% | -4.8% |
| MRK | New | MERCK & CO INC | $31,427,000 | – | 558,500 | +100.0% | 5.28% | – |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $31,118,000 | +24.0% | 896,771 | +21.1% | 5.23% | +36.7% |
| ANTM | Sell | ANTHEM INC | $27,296,000 | -21.3% | 121,310 | -33.6% | 4.59% | -13.2% |
| GILD | Buy | GILEAD SCIENCES INC | $25,639,000 | -5.7% | 357,890 | +6.6% | 4.31% | +4.0% |
| IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $24,247,000 | -9.2% | 506,630 | -4.3% | 4.08% | +0.1% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $23,593,000 | -19.5% | 385,006 | -16.2% | 3.97% | -11.2% |
| BIO | Sell | BIO RAD LABS INCcl a | $22,683,000 | -6.7% | 95,040 | -13.2% | 3.81% | +2.9% |
| PRGO | Sell | PERRIGO CO PLC | $21,750,000 | -8.1% | 249,540 | -10.7% | 3.66% | +1.4% |
| BIIB | Sell | BIOGEN INC | $20,962,000 | -20.3% | 65,800 | -21.7% | 3.52% | -12.1% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $17,816,000 | -38.1% | 1,188,553 | -34.9% | 3.00% | -31.7% |
| NUVA | Buy | NUVASIVE INC | $15,219,000 | +50.0% | 260,200 | +42.2% | 2.56% | +65.4% |
| CI | Buy | CIGNA CORPORATION | $14,860,000 | +138.2% | 73,170 | +119.3% | 2.50% | +162.7% |
| LLY | Sell | LILLY ELI & CO | $12,957,000 | -78.9% | 153,414 | -78.7% | 2.18% | -76.8% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $12,761,000 | +20.8% | 80,000 | +14.3% | 2.14% | +33.1% |
| PDCO | Sell | PATTERSON COMPANIES INC | $10,952,000 | -28.5% | 303,132 | -23.5% | 1.84% | -21.2% |
| MCK | Sell | MCKESSON CORP | $10,498,000 | -42.6% | 67,315 | -43.5% | 1.76% | -36.7% |
| SHPG | Sell | SHIRE PLCsponsored adr | $10,405,000 | -58.1% | 67,075 | -58.6% | 1.75% | -53.8% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $10,267,000 | -15.9% | 150,992 | +2.0% | 1.73% | -7.2% |
| AGN | New | ALLERGAN PLC | $10,240,000 | – | 62,600 | +100.0% | 1.72% | – |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $9,694,000 | +74.7% | 273,312 | +100.0% | 1.63% | +92.6% |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $8,271,000 | -8.7% | 837,192 | +13.5% | 1.39% | +0.7% |
| THC | Sell | TENET HEALTHCARE CORP | $7,059,000 | -16.6% | 465,621 | -9.6% | 1.19% | -8.0% |
| DVA | New | DAVITA INC | $6,263,000 | – | 86,680 | +100.0% | 1.05% | – |
| SRCL | New | STERICYCLE INC | $5,562,000 | – | 81,800 | +100.0% | 0.94% | – |
| MYL | New | MYLAN N V | $5,558,000 | – | 131,361 | +100.0% | 0.93% | – |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $3,837,000 | -35.2% | 275,024 | -14.1% | 0.64% | -28.5% |
| IONS | New | IONIS PHARMACEUTICALS INC | $3,124,000 | – | 62,100 | +100.0% | 0.52% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $2,700,000 | – | 52,500 | +100.0% | 0.45% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $2,434,000 | – | 50,000 | +100.0% | 0.41% | – |
| JUNO | New | JUNO THERAPEUTICS INC | $1,984,000 | – | 43,400 | +100.0% | 0.33% | – |
| RDUS | Buy | RADIUS HEALTH INC | $1,658,000 | +9.8% | 52,173 | +33.2% | 0.28% | +21.3% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $1,194,000 | – | 9,400 | +100.0% | 0.20% | – |
| OMI | Exit | OWENS & MINOR INC NEW | $0 | – | -175,874 | -100.0% | -0.78% | – |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -422,261 | -100.0% | -1.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.